Skip to content

Clinical trials

Depressive Disorder trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Depressive Disorder Country / region: Poland Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20071
20082
20101
20112
20121
20142
20201
20221
20243
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Recruiting7
Unknown status2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Otsuka Pharmaceutical Development & Commercialization, Inc.5
Takeda3
Eli Lilly and Company2
GlaxoSmithKline2
Jakub Antczak2
Seaport Therapeutics2
Cybin IRL Limited1
Medical University of Gdansk1
Medical University of Lodz1
Medical University of Warsaw1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Depressive Disorder22
Major Depressive Disorder16
Mood Disorders10
Mental Disorders6
Anxiety Disorders5
Anhedonia2
Bipolar Disorder2
Personality Disorders2
Adjustment Disorders1
Cognitive Dysfunction1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.